Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-02T21:41:50.552Z Has data issue: false hasContentIssue false

Chapter 4 - Functional anatomy of the FDG image

from Part I - General concepts of PET and PET/CT imaging

Published online by Cambridge University Press:  05 September 2012

Victor H. Gerbaudo
Affiliation:
Brigham and Women's Hospital, Harvard Medical School
Get access

Summary

The physiologic basis of FDG uptake

18F-fluorodeoxyglucose (FDG) is an index molecule for glucose metabolism, a highly complex physiologic process. It is practically a truism that malignant cells proliferate rapidly, and thus tend to have a high metabolic rate (1, 2). However, this statement conceals as much as it reveals. The “metabolism” depicted by a PET scan image cannot be treated as a simple continuum, with benign and inert tissues at the low end (white = “good”), and rampant malignancies at the high end (black = “bad”). There are many kinds of metabolism, and glucose is not the only metabolic currency. Nor is glucose metabolism uniform; it has many competing pathways, often within the same cell. These include both catabolic (energy-producing) or anabolic (energy-consuming) processes, such as the pentose phosphate pathway.

FDG uptake does not directly correspond to the presence or activity of any single molecular target. Every count in every pixel on an ordinary PET scan is a summation of numerous factors, including delivery of tracer molecules to the tissues (plasma input function) and the microscopic and macroscopic architecture of the tissue itself. These are not academic trivia; intimate understanding of these factors is essential for accurate interpretation of PET images. Oversimplification is the most common and perhaps the most dangerous error in reading PET scans.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Warburg, O.On respiratory impairment in cancer cellsScience 1956 124 269Google ScholarPubMed
Warburg, OWind, FNegelein, E.The metabolism of tumors in the bodyJ Gen Physiol 1927 8 519CrossRefGoogle Scholar
Carruthers, A.Facilitated diffusion of glucosePhysiol Rev 1990 70 1135CrossRefGoogle ScholarPubMed
Uldry, MThorens, B.The SLC2 family of facilitated hexose and polyol transportersPflugers Arch 2004 447 480CrossRefGoogle ScholarPubMed
Crane, RKDorando, FC.On the mechanism of Na+-dependent glucose transportAnn N Y Acad Sci 1980 339 46CrossRefGoogle ScholarPubMed
Moran, JKLee, HBBlaufox, MD.Optimization of urinary FDG excretion during PET imagingJ Nucl Med 1999 40 1352Google ScholarPubMed
Anderson, JWHerman, RHTyrrell, JBCohn, RM.Hexokinase: a compartmented enzymeAm J Clin Nutr 1971 24 642CrossRefGoogle ScholarPubMed
Purich, DLFromm, HJRudolph, FB.The hexokinases: kinetic, physical, and regulatory propertiesAdv Enzymol Relat Areas Mol Biol 1973 39 249Google ScholarPubMed
Torizuka, TTamaki, NInokuma, TIn vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PETJ Nucl Med 1995 36 1811Google ScholarPubMed
Britz-Cunningham, SHMillstine, JWGerbaudo, VH.Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellumClin Nucl Med 2008 33 681CrossRefGoogle ScholarPubMed
Boerner, ARVoth, ETheissen, PGlucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PEExp Clin Endocrinol Diabetes 2000 108 191CrossRefGoogle ScholarPubMed
Park, CHLee, EJKim, JKJoo, HJJang, JS.Focal F-18, FDGuptake in a nontoxic autonomous thyroid noduleClin Nucl Med 2002 27 136Google Scholar
Ramos, CDChisin, RYeung, HWLarson, SMMacapinlac, HA.Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumorClin Nucl Med 2001 26 193CrossRefGoogle ScholarPubMed
Kang, KWKim, SKKang, HSPrevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjectsJ Clin Endocrinol Metab 2003 88 4100CrossRefGoogle ScholarPubMed
Gerbaudo, VHJulius, B.Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imagingEur J Radiol 2007 64 401CrossRefGoogle ScholarPubMed
Kamel, EMMcKee, TACalcagni, MLOccult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignanciesEur J Nucl Med Mol Imaging 2005 32 641CrossRefGoogle ScholarPubMed
Nguyêñ, VTMossberg, KATewson, TJTemporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucoseAm J Physiol 1990 259 H1022Google ScholarPubMed
Choi, YBrunken, RCHawkins, RAFactors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humansEur J Nucl Med 1993 20 308CrossRefGoogle ScholarPubMed
Gontier, EFourme, EWartski, MHigh and typical 18F-FDG bowel uptake in patients treated with metforminEur J Nucl Med Mol Imaging 2008 35 95CrossRefGoogle ScholarPubMed
Ozülker, TOzülker, FMert, MOzpaçaci, T.Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drugEur J Nucl Med Mol Imaging 2010 37 1011CrossRefGoogle ScholarPubMed
Oh, JRSong, HCChong, AImpact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metforminAm J Roentgenol 2010 195 1404CrossRefGoogle Scholar
Lerman, HMetser, UGrisaru, DNormal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CTJ Nucl Med 2004 45 266Google ScholarPubMed
Parysow, OMollerach, AMJager, VLow-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scansClin Nucl Med 2007 32 351CrossRefGoogle ScholarPubMed
Williams, GKolodny, GM.Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PETAm J Roentgenol 2008 190 1406CrossRefGoogle ScholarPubMed
Aluise, CDSultana, RTangpong, JChemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunctionAdv Exp Med Biol 2010 678 147CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×